Company News, Financial News

J&J Reports Q2 Results

Neutrogena, Aveeno and Listerine help propel consumer sales in US.

Author Image

By: Christine Esposito

Editor-in-Chief

Johnson & Johnson recorded sales of $18.5 billion for the second quarter of 2016, an increase of 3.9% as compared to the second quarter of 2015. Operational sales results increased 5.3% and the negative impact of currency was 1.4%, according to the company.   Domestic sales increased 7.4% while international sales increased 0.4%, reflecting operational growth of 3.1% and a negative currency impact of 2.7%.  Excluding the net impact of acquisitions, divestitures and hepatitis C sales, on a...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters